NDC 75987-130

TEPEZZA

Teprotumumab

TEPEZZA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Horizon Therapeutics Usa, Inc.. The primary component is Teprotumumab.

Product ID75987-130_9285f19c-2f93-4930-9c4b-d97ea8265afb
NDC75987-130
Product TypeHuman Prescription Drug
Proprietary NameTEPEZZA
Generic NameTeprotumumab
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-01-21
Marketing CategoryBLA /
Application NumberBLA761143
Labeler NameHorizon Therapeutics USA, Inc.
Substance NameTEPROTUMUMAB
Active Ingredient Strength500 mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 75987-130-15

1 VIAL, SINGLE-DOSE in 1 CARTON (75987-130-15) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Marketing Start Date2020-01-21
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.